This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Clinical and Laboratory Evidence That Aureomycin Stimulates the Growth of Candida Albicans

ROBERTS B. PAPPENFORT, Jr., M.D.; EDITH SPITZER SCHNALL, M.A.

AMA Arch Intern Med. 1951;88(6):729-735.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

AUREOMYCIN, isolated by Duggar in 1948,¹ is an antibiotic biosynthesized by the actinomycete, Streptomyces aureofaciens. It has attained great clinical significance because of its therapeutic activity against a wide bacterial spectrum, which includes a number of Gram-positive and Gram-negative organisms, and it appears to be highly specific against many members of the rickettsial group and some virus-like agents.

The antibiotic is a yellow powder said to be soluble in distilled water and in 5% dextrose solution in distilled water. Solutions in isotonic sodium chloride solution precipitate when a level of more than 1% of the drug is attained. The aqueous solutions are acid and when neutralized or made alkaline deterioration of activity is rapid at room temperature.

After oral administration of a single dose of 0.5 gm., aureomycin appears in the urine in 1 hour and is detectable up to 16 hours, the peak concentration occurring between 2 and . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

From the Department of Dermatology, Columbia-Presbyterian Medical Center.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?